A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience

BACKGROUND/AIMS: The widespread use of cytotoxic chemotherapy and immunosuppressants has resulted in reactivation of hepatitis B virus (HBV) recently becoming an issue. Although rituximab (an anti-CD20 monoclonal antibody) has revolutionized the treatment of lymphoma, recent reports have suggested t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Myung Jin, Lee, Heon Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622856/
https://www.ncbi.nlm.nih.gov/pubmed/23593610
http://dx.doi.org/10.3350/cmh.2013.19.1.51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622856/
https://www.ncbi.nlm.nih.gov/pubmed/23593610
http://dx.doi.org/10.3350/cmh.2013.19.1.51

Ejemplares similares